Regard focuses on AI-driven diagnostics and note generation at the point of care, while PathAI enhances diagnostic accuracy through AI-powered pathology. Regard integrates with multiple healthcare technologies, whereas PathAI is especially known for its FDA-cleared AISight® Dx platform. Both tools present tiered pricing with strong investments in their development stages: Regard at Series B with $81.4M and PathAI via acquisition with $1.2B.
Best for
PathAI is the better choice when the priority is AI-enhanced pathology services for hospitals and labs that require validated diagnostic platforms and integration with major electronic health record systems.
Best for
Regard is the better choice when healthcare providers need a tool that focuses on comprehensive data review and integrates well with a wide range of healthcare management systems.
Key Differences
Verdict
For healthcare providers focused on immediate point-of-care diagnosis, Regard presents a compelling toolkit due to its proactive documentation capabilities. PathAI, on the other hand, stands out for institutions prioritizing pathology, with its AI-powered image analysis and FDA clearance enhancing credibility. Decision-makers should evaluate their needs for diagnostic precision versus breadth of care integration.
PathAI
At PathAI, we’re dedicated to improving patient outcomes with AI-powered pathology and meaningful collaboration with biopharma, laboratories and clini
There are no direct user reviews or social mentions focused on "PathAI" in the information provided. However, if "PathAI" were part of a similar context, user reviews might focus on its capabilities in enhancing AI accuracy and streamlining diagnostic processes as strengths, while potential complaints could revolve around integration issues or pricing. The sentiment surrounding pricing might be sensitive for niche AI tools, generally reflecting an expectation for value relative to high costs. Overall, a tool like PathAI often holds a reputable position in the specialized AI sector for its innovative contributions.
Regard
Regard reviews all data in the medical record to recommend diagnoses and generate a complete note at the point of care - improving care, quality, and
The reviews and social mentions do not provide any specific feedback or insights about "Regard", making it challenging to discern user opinions on the software. Given the lack of detailed user input, it is difficult to outline the main strengths, key complaints, pricing sentiment, or overall reputation of the tool. More targeted user feedback would be needed for a comprehensive analysis.
PathAI
-71% vs last weekRegard
Stable week-over-weekPathAI
Regard
PathAI
Regard
PathAI
Regard
Pricing found: $7
PathAI (8)
Regard (2)
Only in PathAI (5)
Only in Regard (2)
Only in PathAI (15)
Only in Regard (8)
PathAI
Regard
PathAI
Regard
PathAI
No screenshots
Regard
PathAI
Regard
PathAI
100 Tips & Tricks for Building Your Own Personal AI Agent /LONG POST/
*Everything I learned the hard way — 6 weeks, no sleep :), two environments, one agent that actually works.* # The Story I spent six weeks building a personal AI agent from scratch — not a chatbot wrapper, but a persistent assistant that manages tasks, tracks deals, reads emails, analyzes business
Regard
Is Flock just a poor US-centric copy of, globally active Genetec?
I've read all of Genetec's [customer stories](https://www.genetec.com/customer-stories/search) (the PDFs), and although I recognize these, as being Genetec marketing material (at least in part), they do contain insightful information, regarding implementation of surveillance systems; that is, from t
Only in Regard (1)
PathAI is specifically designed to enhance AI-powered pathology diagnostics, making it the superior choice for this use case.
Regard offers a starting price identified at $7 with tiered pricing, while PathAI's higher costing is likely due to its advanced and FDA-cleared technology.
PathAI may offer better community support owing to its larger company size of 280 employees and a broader customer base.
Yes, they can be used together as they serve different aspects of healthcare diagnostics and pathology, provided integration across platforms is managed effectively.
Both tools require some integration effort, but Regard might offer a quicker start for direct care diagnostics, while PathAI could take longer due to its specialized pathology focus and need for specific system integrations.
